TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27480315

Group type: EXPERIMENTAL
Intervention: Blood flow restriction (70% arterial occlusion) during low-load resistance training
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (one set of elbow flexion at 70% 1RM to volitional fatigue)
Number of subjects: 13
Study: 24067745

Group type: EXPERIMENTAL
Intervention: Grapefruit juice (200 ml, three times daily for 3 days)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 14
Study: 23469595

Group type: EXPERIMENTAL
Intervention: Shuangshen Tongguan Capsule (STC), 4 pills each time, three times daily
Number of subjects: 129

Group type: COMPARATOR
Intervention: STC Placebo
Number of subjects: 129
Study: 20038536

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 127
Study: 17698615

Group type: EXPERIMENTAL
Intervention: Pramlintide (60 or 120 microg b.i.d./t.i.d.)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 212
Study: 15764047

Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide 0.01% in oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study: 11838013

Group type: EXPERIMENTAL
Intervention: Medline searches using MeSH-terms for endodontics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medline searches using MeSH-terms for orthodontics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medline searches using MeSH-terms for pediatric dentistry
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medline searches using MeSH-terms for public health dentistry
Number of subjects: 0
Study: 9725399

Group type: EXPERIMENTAL
Intervention: Low-dose aprotinin
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: High-dose aprotinin
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control
Number of subjects: 45
Study: 7530944

Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg/day
Number of subjects: 1600

Group type: EXPERIMENTAL
Intervention: Finasteride 1 mg/day
Number of subjects: 1600

Group type: EXPERIMENTAL
Intervention: Finasteride (both dosages)
Number of subjects: 1600

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1600
Study: 2536516

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 15
Study: 30944162

Group type: EXPERIMENTAL
Intervention: 7 days of peroral metronidazole/amoxicillin antibiotic treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: No antibiotic treatment (control group)
Number of subjects: 0
Study: 27055804

Group type: EXPERIMENTAL
Intervention: 17 minutes of motor imagery with music, six times per week for 4 weeks
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 17 minutes of motor imagery with metronome cues, six times per week for 4 weeks
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 112
Study: 25485893

Group type: EXPERIMENTAL
Intervention: Resistance exercise (8 exercises, 2 sets of 10 repetitions at an intensity of 5‐7 in the OMNI Resistance Exercise Scale)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (rest for 30 min)
Number of subjects: 14
Study: 23787722

Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose (FCM)
Number of subjects: 459

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 459
Study: 22099238

Group type: EXPERIMENTAL
Intervention: AchieveTogether (12-week web-based intervention)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 100
Study: 19440788

Group type: EXPERIMENTAL
Intervention: Kugel repair
Number of subjects: 40

Group type: COMPARATOR
Intervention: TEP repair
Number of subjects: 40
Study: 15641975

Group type: EXPERIMENTAL
Intervention: AH plus
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: EndoRez
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control
Number of subjects: 55
Study: 10589608

Group type: EXPERIMENTAL
Intervention: NO delivered into the MO (100 ppm)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (CPB without NO)
Number of subjects: 47
Study: 8756815

Group type: EXPERIMENTAL
Intervention: rhDNase 2.5 mg twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: rhDNase once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (excipient only) inhalation
Number of subjects: 0
Study: 2017519

Group type: EXPERIMENTAL
Intervention: Fluoxetine treatment (chronic)
Number of subjects: 6

Group type: COMPARATOR
Intervention: mCPP (0.5 mg/kg)
Number of subjects: 6
Study: 6210751

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 31005993

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 482
Study: 31068182

Group type: EXPERIMENTAL
Intervention: Platelet count quintile grouping (Q1, Q3, Q5)
Number of subjects: 1797

Group type: COMPARATOR
Intervention: Normal platelet counts (≥150 to <300 × 10^9/L)
Number of subjects: 1797

Group type: EXPERIMENTAL
Intervention: Platelet count
Number of subjects: 1797
Study: 29554191

Group type: EXPERIMENTAL
Intervention: Parent-reported stuttering severity ratings (SRs)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Percentage of syllables stuttered (%SS)
Number of subjects: 3
Study: 27857631

Group type: EXPERIMENTAL
Intervention: Passive soft tissue therapy
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Active soft tissue therapy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham procedure (Control group)
Number of subjects: 42
Study: 24317552

Group type: EXPERIMENTAL
Intervention: 30 % elbow extensor activation
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 30 % elbow flexor activation
Number of subjects: 11
Study: 20965712

Group type: EXPERIMENTAL
Intervention: Beclomethasone/formoterol (200/12 μg)
Number of subjects: 703

Group type: COMPARATOR
Intervention: Budesonide/formoterol (400/12 μg)
Number of subjects: 703

Group type: COMPARATOR
Intervention: Formoterol (12 μg)
Number of subjects: 703
Study: 17346628

Group type: EXPERIMENTAL
Intervention: Basiliximab
Number of subjects: 35

Group type: COMPARATOR
Intervention: RATG
Number of subjects: 35
Study: 15319308

Group type: EXPERIMENTAL
Intervention: Simple monetary gambling tasks with no active choices (experiment 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simple monetary gambling tasks with no overt actions (experiment 2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gambling task with outcomes contingent upon participants' response choices
Number of subjects: 0
Study: 12079598

Group type: EXPERIMENTAL
Intervention: Real auricular acupuncture intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham or placebo auricular acupuncture
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined experimental and control groups
Number of subjects: 30
Study: 9559810

Group type: EXPERIMENTAL
Intervention: Grapefruit juice
Number of subjects: 12

Group type: COMPARATOR
Intervention: Water
Number of subjects: 12
Study: 8536392

Group type: EXPERIMENTAL
Intervention: Angiographic characteristics of patients who suffered a stroke (n = 50)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Angiograms of 50 patients who suffered a stroke
Number of subjects: 150
Study: 2238169

Group type: EXPERIMENTAL
Intervention: rHu‐EPO
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 29369660

Group type: EXPERIMENTAL
Intervention: Peer mentoring intervention
Number of subjects: 22
Study: 28469157

Group type: EXPERIMENTAL
Intervention: Deferiprone 10 mg/kg BID
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Deferiprone 15 mg/kg BID
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Deferiprone 30 mg/kg
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Deferiprone
Number of subjects: 22
Study: 25895855

Group type: EXPERIMENTAL
Intervention: Religious coping
Number of subjects: 436
Study: 25153911

Group type: EXPERIMENTAL
Intervention: Fructose restricted diet (group A)
Number of subjects: 103

Group type: COMPARATOR
Intervention: No diet (group B)
Number of subjects: 103
Study: 21601396

Group type: EXPERIMENTAL
Intervention: Prehydration using a carbohydrate‐electrolyte beverage (CE)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control conditions (Cont) with no prehydration
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Prehydration using water (W)
Number of subjects: 14
Study: 19804430

Group type: EXPERIMENTAL
Intervention: Temsirolimus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interferon-alpha
Number of subjects: 0
Study: 17426326

Group type: EXPERIMENTAL
Intervention: Environmental approach for weight gain prevention
Number of subjects: 670

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 670
Study: 16354214

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Budesonide (BUD)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 82
Study: 12037450

Group type: EXPERIMENTAL
Intervention: Calcipotriol ointment/scalp solution (80-100 g/week and 30-50 ml/week, respectively)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Dithranol/tar regimen
Number of subjects: 88
Study: 10574363

Group type: EXPERIMENTAL
Intervention: Pursuit maintenance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stimuli flashed ahead of the pursuit target
Number of subjects: 0
Study: 8535669

Group type: EXPERIMENTAL
Intervention: Ileal conduit
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Colonic conduit
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Continent caecal reservoir
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conduit diversion (both ileal and colonic)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ureteric reimplantation
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Balloon dilatation
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Uretero-intestinal anastomoses
Number of subjects: 56
Study: 2230067

Group type: EXPERIMENTAL
Intervention: Adinazolam
Number of subjects: 30

Group type: COMPARATOR
Intervention: Desipramine
Number of subjects: 30
Study: 139852

Group type: EXPERIMENTAL
Intervention: Metronidazole (400 mg three times daily for 10-20 days)
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 229

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 229
Study: 31558370

Group type: EXPERIMENTAL
Intervention: Emotional Freedom Techniques (EFT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Progressive Muscle Relaxation (PMR)
Number of subjects: 40
Study: 31276710

Group type: COMPARATOR
Intervention: Emotional messaging intervention
Number of subjects: 180

Group type: COMPARATOR
Intervention: Informational messaging intervention
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control condition (messages on sugar consumption)
Number of subjects: 180
Study: 28067982

Group type: EXPERIMENTAL
Intervention: GAN group (posterior branch preserved)
Number of subjects: 130

Group type: COMPARATOR
Intervention: non-GAN group (posterior branch ligated)
Number of subjects: 130
Study: 25867865

Group type: EXPERIMENTAL
Intervention: Resistance exercise training (RET) for 20 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (untrained men)
Number of subjects: 20
Study: 23453095

Group type: EXPERIMENTAL
Intervention: Enhanced shielding with a 0.5‐mm lead apron across the patient's abdomen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard shielding
Number of subjects: 0
Study: 21597217

Group type: EXPERIMENTAL
Intervention: Light-irradiated intensity of 600 mW/cm(2) with translucent shade resin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Light-irradiated intensity of 350 mW/cm(2) with translucent shade resin using SE and BF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Light-irradiated intensity of 350 mW/cm(2) with TS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Light-irradiated intensity of 600 mW/cm(2) with opaque shade resin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Light-irradiated intensity of 350 mW/cm(2) with opaque shade resin
Number of subjects: 0
Study: 19548028

Group type: EXPERIMENTAL
Intervention: Double Tract (DT) reconstruction
Number of subjects: 44

Group type: COMPARATOR
Intervention: Roux-en-Y (R-Y) reconstruction
Number of subjects: 44
Study: 17584567

Group type: EXPERIMENTAL
Intervention: Thiazolidinedione therapy (pioglitazone or rosiglitazone)
Number of subjects: 235
Study: 15089940

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide suspension [Ca(OH)2]
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Glutaraldehyde based dentine primer (GDP)
Number of subjects: 36
Study: 11294429

Group type: EXPERIMENTAL
Intervention: Non-steroidal anti-inflammatory drugs post-operatively for 3-6 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simple analgesia in the first 1-2 days following surgery and a well-planned home-based exercise program
Number of subjects: 0
Study: 9257419

Group type: EXPERIMENTAL
Intervention: Spreadsheet method for displaying drug dosing histories
Number of subjects: 0
Study: 8177603

Group type: EXPERIMENTAL
Intervention: Infrared coagulation
Number of subjects: 1537

Group type: COMPARATOR
Intervention: Rubber band ligation
Number of subjects: 1537

Group type: COMPARATOR
Intervention: Sclero cryo therapy
Number of subjects: 1537
Study: 3308389

Group type: EXPERIMENTAL
Intervention: L-5-HTP
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 29320587

Group type: COMPARATOR
Intervention: Basic skin care regimen following hyaluronic acid filler and neurotoxin treatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nu‐Derm® skin care system (Obagi Medical Products, Inc) following treatment
Number of subjects: 20
Study: 27097354

Group type: EXPERIMENTAL
Intervention: Albumin
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Low-dose albumin plus terlipressin
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Midodrine
Number of subjects: 200

Group type: COMPARATOR
Intervention: Albumin (control group)
Number of subjects: 200
Study: 26226481

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 22
Study: 24152576

Group type: EXPERIMENTAL
Intervention: Olive oil application
Number of subjects: 0

Group type: COMPARATOR
Intervention: HOFA application
Number of subjects: 0
Study: 21309374

Group type: EXPERIMENTAL
Intervention: Sensory Integration (SI) treatment group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fine motor treatment group
Number of subjects: 0
Study: 17951278

Group type: EXPERIMENTAL
Intervention: Intravenous salbutamol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lung lavage fluid from patients treated with salbutamol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In vitro salbutamol
Number of subjects: 0
Study: 17027730

Group type: EXPERIMENTAL
Intervention: Oral misoprostol
Number of subjects: 1620

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1620
Study: 15080821

Group type: EXPERIMENTAL
Intervention: Desloratadine (DES) 5 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fexofenadine (FEX) 180 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Levocetirizine (LEV) 5 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 16
Study: 11280457

Group type: EXPERIMENTAL
Intervention: 500 mg azithromycin once a day for four days per month along with 0.05% topical tretinoin for a total of 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: 100 mg doxycycline daily in addition to topical 0.05% tretinoin cream for a total of 12 weeks
Number of subjects: 60
Study: 9249114

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 8504628

Group type: EXPERIMENTAL
Intervention: Intravenous low dose aspirin (50 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intravenous high dose aspirin (500 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 3323256

Group type: EXPERIMENTAL
Intervention: A-49816 (0.5 to 20 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 31703936

Group type: EXPERIMENTAL
Intervention: Full dose (n=14)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 1/5th dose (n=17)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 1/25th dose (n=13)
Number of subjects: 44
Study: 30549483

Group type: EXPERIMENTAL
Intervention: News article featuring an interview with a suicide expert disclosing personal experience of suicidal ideation
Number of subjects: 545

Group type: EXPERIMENTAL
Intervention: News article featuring an interview with a suicide expert without disclosure of personal experience
Number of subjects: 545

Group type: COMPARATOR
Intervention: Article unrelated to suicide
Number of subjects: 545
Study: 27608368

Group type: EXPERIMENTAL
Intervention: Brief home-based social work motivational intervention (HSWMI)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual consulting services (Control)
Number of subjects: 56
Study: 24332384

Group type: EXPERIMENTAL
Intervention: Active TMS
Number of subjects: 301

Group type: COMPARATOR
Intervention: Sham TMS
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Active TMS (open-label extension)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Active TMS (24-week follow-up)
Number of subjects: 301
Study: 21961441

Group type: EXPERIMENTAL
Intervention: Constraint therapy plus electrical stimulation
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Constraint therapy
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Occupational therapy
Number of subjects: 68
Study: 20724559

Group type: EXPERIMENTAL
Intervention: Hyperoxia (inspired PO(2) > 250 Torr)
Number of subjects: 9
Study: 19000399

Group type: EXPERIMENTAL
Intervention: Research information sheet for practices, expenses of approximately £3000 per practice, research activity agreements with payment schedule based on deliverables.
Number of subjects: 119

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 119
Study: 16189431

Group type: EXPERIMENTAL
Intervention: MRI planimetry of aortic valve area (MRI‐AVA)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Transesophageal echocardiography (TEE‐AVA)
Number of subjects: 33
Study: 12640257

Group type: EXPERIMENTAL
Intervention: Irbesartan (angiotensin II type 1 receptor antagonist)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Atenolol (beta1-adrenoceptor antagonist)
Number of subjects: 90
Study: 10460983

Group type: EXPERIMENTAL
Intervention: Luffa comp.-Heel nasal spray (0.14 ml per application, 4 times per day)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Cromolyn sodium spray (control)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Luffa comp.-Heel nasal spray
Number of subjects: 146

Group type: COMPARATOR
Intervention: Cromolyn sodium spray
Number of subjects: 146
Study: 7754270

Group type: EXPERIMENTAL
Intervention: Peripheral quantitative computed tomography (pQCT, Densiscan type, thin‐ and multi‐layer technology)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Screening program for identifying women at risk of rapid bone loss
Number of subjects: 70
Study: 2491883

Group type: EXPERIMENTAL
Intervention: Ifosfamide 2.0g/m2 days 1 to 4 with mesna uroprotection
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Bolus administration of ifosfamide
Number of subjects: 124

Group type: COMPARATOR
Intervention: Continuous infusion schedule of ifosfamide
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Performance score 0-2 prior to chemotherapy
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Performance score 0-1 prior to chemotherapy
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Neurotoxicity
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Serum bicarbonate less than 20
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Hematuria
Number of subjects: 124
Study: 31399883

Group type: EXPERIMENTAL
Intervention: Dry syrup formulation (2%, 1g containing 20mg of memantine hydrochloride)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Film-coated tablet (reference product)
Number of subjects: 0
Study: 28117542

Group type: COMPARATOR
Intervention: NORMAL-DUAL
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: DUAL-NORMAL
Number of subjects: 58
Study: 25185252

Group type: EXPERIMENTAL
Intervention: Probing
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Bicanalicular silastic intubation
Number of subjects: 181
Study: 24001787

Group type: EXPERIMENTAL
Intervention: CBT-based website with nurse support
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: CBT-based website alone
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: CBT-based website
Number of subjects: 31
Study: 21812265

Group type: EXPERIMENTAL
Intervention: Chinese herbal retention enema combined with intrauterine douching
Number of subjects: 131

Group type: COMPARATOR
Intervention: Direct IVF/ICSI
Number of subjects: 131
Study: 20031730

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting TAXUS stent
Number of subjects: 7492

Group type: COMPARATOR
Intervention: Simple-use cases (single-vessel and single-stent)
Number of subjects: 7492

Group type: COMPARATOR
Intervention: Expanded use cases
Number of subjects: 7492

Group type: EXPERIMENTAL
Intervention: Early ST
Number of subjects: 7492

Group type: EXPERIMENTAL
Intervention: Late ST
Number of subjects: 7492

Group type: EXPERIMENTAL
Intervention: Very late ST
Number of subjects: 7492

Group type: EXPERIMENTAL
Intervention: Patients with early ST
Number of subjects: 7492

Group type: EXPERIMENTAL
Intervention: Patients with very late ST
Number of subjects: 7492

Group type: EXPERIMENTAL
Intervention: Premature thienopyridine discontinuation
Number of subjects: 7492
Study: 17640415

Group type: EXPERIMENTAL
Intervention: Carob fibre (50 g)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (no carob fibre)
Number of subjects: 19
Study: 15173796

Group type: EXPERIMENTAL
Intervention: Soft-tipped Teflon tracer 0.035-inch guidewire (Group A)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Traditional methods of cannulation (Group B)
Number of subjects: 400